We congratulate Jenny (Bojuan Deng) on her patent, U.S. Patent No. 7,863,444, issued January 4, 2011! U.S. Patent No. 7,863,444 is directed at a genus of kinase inhibitors, 4-aminopyrrolopyrimidines, which can be used in treating cancer, hyperproliferative disorders, rheumatoid artheritis, disorders of the immune system, transplant rejection, and inflammatory disorders.